AMH and Dosing Regimens for Initial IVF Stimulation Protocols
Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
This is a research study on a hormone in women called anti-mullerian hormone (AMH) an
indicator of the amount of egg reserve in the ovaries. The research involves a blood draw to
determine the AMH level. This knowledge will help the investigators decide a dosage of
gonadotropins, the hormones used to stimulate the production of more than one egg for use in
an in vitro fertilization (IVF) cycle. The amount of gonadotropin given has to be tailored to
each individual participant. The investigators can use information about the participant and
the hormone levels to determine this dosage and the chances of becoming pregnant as a result
of IVF treatment. The reason the investigators are doing this research is to find out if
basing the gonadotropin dosage solely on the participant's AMH level will give the
investigators a better result than the previous method based on age and other hormone levels.